Cargando…
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
Pancreatic ductal adenocarcinoma (PDAC), has recently been found to be a heterogeneous disease, although the extension of its diversity remains to be fully understood. Here, we harmonize transcriptomic profiles derived from both PDAC epithelial and microenvironment cells to develop a Master Regulato...
Autores principales: | Fraunhoffer, Nicolas A., Abuelafia, Analía Meilerman, Bigonnet, Martin, Gayet, Odile, Roques, Julie, Nicolle, Remy, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Iovanna, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385633/ https://www.ncbi.nlm.nih.gov/pubmed/35978026 http://dx.doi.org/10.1038/s41698-022-00299-z |
Ejemplares similares
-
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022) -
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022) -
Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023) -
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021) -
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)